Non-Applicability of Statement of Deviation or Variation under Regulation 32 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences Ltd has filed a compliance confirmation with BSE stating that the Statement of Deviation or Variation under SEBI Regulation 32 is not applicable to the company. The company clarified that it has not raised any funds through a public issue, rights issue, preferential issue, or Qualified Institutions Placement (QIP) during the relevant period. Since there are no proceeds from such issues, there are no deviations or variations to report. The filing was signed by Siddhi Shah, Company Secretary & Compliance Officer, on 14th July 2025.
This is a routine regulatory compliance filing with no material impact on shareholders or stock price. It simply confirms the absence of any recent fund-raising activity that would require deviation reporting.